28 is the total number of securities Essex Woodlands Management, Inc. has owned. The longest Essex Woodlands Management, Inc. has owned a single stock is 42 quarters.
| Period | Weighting | Quarter | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Ticker | Name | Longest | Shortest | Min. | Avg. | Max. | First | Latest | ↓ Count |
| MNOV | MEDICINOVA INC | 42 | 42 | 0.49% | 1.97% | 6.50% | Q2 2013 | Q3 2023 | 42 |
| RVNC | REVANCE THERAPEUTICS INC | 39 | 39 | 1.68% | 20.36% | 44.64% | Q1 2014 | Q3 2023 | 39 |
| AXGN | AXOGEN INC | 26 | 26 | 0.62% | 14.89% | 43.30% | Q3 2015 | Q4 2021 | 26 |
| ELGX | ENDOLOGIX INC | 24 | 24 | 0.64% | 6.57% | 22.47% | Q2 2013 | Q1 2019 | 24 |
| ABMD | ABIOMED INC | 20 | 20 | 12.85% | 33.68% | 52.05% | Q2 2013 | Q1 2018 | 20 |
| CORI | CORIUM INTL INC | 20 | 20 | 1.34% | 13.74% | 23.48% | Q2 2014 | Q1 2019 | 20 |
| TELA | TELA BIO, INC. | 16 | 16 | 3.68% | 12.65% | 31.52% | Q4 2019 | Q3 2023 | 16 |
| VERO | VENUS CONCEPT, INC. | 16 | 16 | 1.73% | 7.62% | 21.26% | Q4 2019 | Q3 2023 | 16 |
| ACUR | ACURA PHARMACEUTICALS INC | 15 | 15 | 0.08% | 0.44% | 1.45% | Q3 2015 | Q1 2019 | 15 |
| CBIO | CATALYST BIOSCIENCES INC | 15 | 15 | 0.07% | 0.34% | 1.03% | Q3 2015 | Q1 2019 | 15 |
| CBIO | CATALYST BIOSCIENCES INC | 13 | 13 | 0.01% | 0.14% | 0.33% | Q2 2019 | Q2 2022 | 13 |
| ENTL | ENTELLUS MED INC | 12 | 12 | 9.68% | 14.41% | 18.15% | Q1 2015 | Q4 2017 | 12 |
| EYPT | EYEPOINT PHARMACEUTICA... | 12 | 12 | 5.56% | 12.31% | 27.59% | Q4 2020 | Q3 2023 | 12 |
| BVS | BIOVENTUS | 11 | 11 | 7.49% | 30.87% | 41.24% | Q1 2021 | Q3 2023 | 11 |
| MDXG | MIMEDX GROUP, INC. | 10 | 10 | 26.66% | 36.06% | 46.20% | Q4 2020 | Q1 2023 | 10 |
| ACUR | ACURA PHARMACEUTICALS INC | 9 | 9 | 1.37% | 5.37% | 14.34% | Q2 2013 | Q2 2015 | 9 |
| ZIOP | ZIOPHARM ONCOLOGY INC | 7 | 7 | 2.13% | 4.04% | 6.42% | Q2 2013 | Q4 2014 | 7 |
| CRIS | CURIS INC | 7 | 7 | 0.09% | 0.30% | 0.69% | Q2 2013 | Q4 2014 | 7 |
| ECTE | ECHO THERAPEUTICS INC | 7 | 7 | 0.00% | 0.01% | 0.02% | Q2 2013 | Q4 2014 | 7 |
| PTN | PALATIN TECHNOLOGIES INC | 7 | 7 | 0.01% | 0.01% | 0.01% | Q2 2013 | Q4 2014 | 7 |
| EYPT | EYEPOINT PHARMACEUTICA... | 6 | 6 | 11.58% | 28.65% | 47.25% | Q2 2019 | Q3 2020 | 6 |
| ELGXQ | ENDOLOGIX INC | 6 | 6 | 0.00% | 0.31% | 0.80% | Q2 2019 | Q3 2020 | 6 |
| PSDV | PSIVIDA | 5 | 5 | 2.30% | 22.92% | 37.35% | Q1 2018 | Q1 2019 | 5 |
| HZNP | HORIZON PHARMA INC | 5 | 5 | 10.07% | 16.66% | 21.65% | Q2 2013 | Q2 2014 | 5 |
| CO | CHINA CORD BLOOD CORP | 4 | 4 | 0.09% | 1.62% | 2.60% | Q2 2013 | Q1 2014 | 4 |
| LGND | LIGAND PHARMACEUTICALS... | 4 | 4 | 0.50% | 0.70% | 0.99% | Q2 2016 | Q1 2017 | 4 |
| SONENDO, INC. | 3 | 3 | 1.42% | 1.98% | 2.58% | Q4 2021 | Q2 2022 | 3 | |
| SLTM | SOLTA MED INC | 3 | 3 | 1.51% | 1.88% | 2.32% | Q2 2013 | Q4 2013 | 3 |
Download | |||||||||
The securities at the top of the list , including MEDICINOVA INC, REVANCE THERAPEUTICS INC, and AXOGEN INC, are the highest-conviction holdings of Essex Woodlands Management, Inc..
The conviction is calculated by counting the number of quarters a security has been reported by Essex Woodlands Management, Inc.. The higher the number, the higher the conviction and longer the holding period.
This page lists all the securities that Essex Woodlands Management, Inc. owns currently or has owned in the past.